Loading…
Acme Universal Safezone 9 (BSE 544964)₹102.25−1.21%Footwear
For the year to Mar 2026, sales were ₹203 Cr and net profit −₹4.99 Cr.
Company filings, standalone accounts
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales | 156 | 177 | 187 | 203 |
| Expenses | 149 | 165 | 178 | 190 |
| Operating Profit | 8.98 | 14.97 | 10.98 | 14.96 |
| OPM % | 6.0% | 8.0% | 6.0% | 7.0% |
| Other Income | 2.01 | 3.01 | 7.02 | −6.02 |
| Interest | 1.99 | 3.01 | 2.99 | 2.99 |
| Depreciation | 4.99 | 4.99 | 4.99 | 8.98 |
| Profit before tax | 4.99 | 9.97 | 9.98 | −3.99 |
| Tax % | 37.0% | 25.0% | 25.0% | 56.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | −9.01 |
| Net Profit | 2.99 | 7.98 | 7.98 | −4.99 |
| EPS (Rs) | 2.22 | 5.58 | 5.32 | −3.89 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 4.01 | 4.01 | 5.01 | 14.04 |
| Reserves | 30.00 | 38.06 | 54.05 | 38.98 |
| Borrowings | 38.09 | 45.14 | 50.13 | 58.13 |
| Other Liabilities | 35.17 | 33.16 | 28.14 | 36.17 |
| Total Liabilities | 107 | 119 | 136 | 147 |
| Fixed Assets | 32.03 | 31.05 | 36.07 | 63.07 |
| CWIP | 6.02 | 18.04 | 27.07 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 69.22 | 70.28 | 73.19 | 84.25 |
| Inventories | 29.12 | 29.47 | 28.91 | 35.21 |
| Trade receivables | 26.16 | 25.83 | 30.17 | 28.70 |
| Cash & equivalents | 2.72 | 2.26 | 2.57 | 3.27 |
| Total Assets | 107 | 119 | 136 | 147 |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Cash from operating activity | 1.01 | 11.02 | −2,33,139 | 7.02 |
| Cash from investing activity | −6.99 | −14.99 | 2,32,242 | −11.99 |
| Cash from financing activity | 6.01 | 4.01 | 6.01 | 5.01 |
| Net cash flow | 0.00 | 0.00 | 0.00 | 0.99 |
| Capex | 8.67 | 15.42 | 18.88 | 12.70 |
| Free cash flow | −6.97 | −3.99 | −2,31,915 | −4.98 |
| CFO / OP % | 28.1% | 91.1% | −20,95,047.0% | 64.1% |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor days | 62 | 54 | 60 | 53 |
| Inventory days | 94 | 85 | 79 | 91 |
| Days payable | 87 | 68 | 65 | 60 |
| Cash conversion cycle | 67 | 69 | 71 | 82 |
| Working capital days | 15 | 14 | 15 | 11 |
| ROCE % | — | 16.0% | 14.1% | 10.0% |
Acme Universal Safezone 9's sales for the year to Mar 2026 were ₹203 Cr.
Net profit for the year to Mar 2026 was −₹4.99 Cr. Earnings per share over the same trailing period were ₹−3.89.
Acme Universal Safezone 9 reported borrowings of ₹58.13 Cr at Mar 2026, against cash and equivalents of ₹3.27 Cr.
Cash from operations was ₹7.02 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹4.98 Cr.